A Prospective Blinded Evaluation of Urine-DNA Testing for Detection of Urothelial Bladder Carcinoma in Patients with Gross Hematuria

Overview

Journal Eur Urol

Specialty Urology

Date 2016 Jul 16

PMID 27417036

Citations 34

Authors

Christina M Dahmcke

Kenneth E Steven

Louise K Larsen

Asger L Poulsen

Ahmad Abdul-Al

Christina Dahl

Per Guldberg

Affiliations

Soon will be listed here.

Abstract

Patient Summary: We tested the possibility of using a urine-based DNA test to check for bladder cancer in patients with visible blood in the urine. Our results show that the test efficiently detects bladder cancer and therefore may be used to greatly reduce the number of patients who would need to undergo cystoscopy.

Citing Articles

Analysis the diagnostic performance of H4C6/SOX1-OT gene methylation in bladder cancer based on urine sample.

Wang W, Yang X, Li W, Cheng J, Wu J, Cai J Sci Rep. 2025; 15(1):6961.

PMID: 40011626 PMC: 11865265. DOI: 10.1038/s41598-025-91337-w.

Epigenetic Biomarkers as a New Diagnostic Tool in Bladder Cancer-From Early Detection to Prognosis.

Jaszek N, Bogdanowicz A, Siwiec J, Starownik R, Kwasniewski W, Mlak R J Clin Med. 2024; 13(23).

PMID: 39685620 PMC: 11642161. DOI: 10.3390/jcm13237159.

A narrative review of advances in the management of urothelial cancer: Diagnostics and treatments.

Wu S, Xiong S, Li J, Hong G, Xie Y, Tang Q Bladder (San Franc). 2024; 11(1):e21200003.

PMID: 39308962 PMC: 11413229. DOI: 10.14440/bladder.2024.0003.

Advances in Liquid Biopsy for Diagnosis of Bladder Cancer.

Seok J, Kwak Y, Kim S, Kim E, Kim A Int Neurourol J. 2024; 28(2):83-95.

PMID: 38956768 PMC: 11222820. DOI: 10.5213/inj.2448198.099.

Distinct longitudinal patterns of urine tumor DNA in patients undergoing surveillance for bladder cancer.

Vedeld H, Pharo H, Sorbo A, Brandt-Winge S, Five M, Jeanmougin M Mol Oncol. 2024; 18(11):2684-2695.

PMID: 38720532 PMC: 11547231. DOI: 10.1002/1878-0261.13639.